MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$909K
Net Income
-$2,911K
Net Profit Margin
-320.24%
EPS
-$0.06
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
909
563
238
266
Cost of revenue
143
84
28
53
Gross profit
766
479
210
213
Research and development
1,200
1,228
1,516
1,685
Selling, general and administrative
2,915
2,720
2,216
1,728
Total operating expenses
4,115
3,948
3,732
3,413
Loss from operations
-3,349
-3,469
-3,522
-3,200
Interest income, net
90
45
75
113
Loss of disposition of assets
-2
-
-
-
Change in fair value of common warrant liability
-350
97
-506
-175
Total other income (expense), net
438
-52
581
288
Net loss
-2,911
-3,521
-2,941
-2,912
Basic EPS
-0.06
-0.09
-0.08
-0.08
Diluted EPS
-0.06
-0.09
-0.08
-0.08
Basic Average Shares
47,298,148
38,032,421
36,713,775
36,646,278
Diluted Average Shares
47,298,148
38,032,421
36,713,775
36,646,278
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Change in fair value of
common warrant...
-$350K
(-200.00%↓ Y/Y)
Interest income, net
$90K
(-32.33%↓ Y/Y)
Net loss
-$2,911K
(-0.55%↓ Y/Y)
Total other income
(expense), net
$438K
(301.84%↑ Y/Y)
Revenues
$909K
(115.40%↑ Y/Y)
Loss of disposition
of assets
-$2K
Loss from operations
-$3,349K
(-25.06%↓ Y/Y)
Gross profit
$766K
(183.70%↑ Y/Y)
Cost of revenue
$143K
(-5.92%↓ Y/Y)
Total operating
expenses
$4,115K
(39.59%↑ Y/Y)
Selling, general and
administrative
$2,915K
(91.52%↑ Y/Y)
Research and development
$1,200K
(-15.85%↓ Y/Y)
Buy us a coffee
RenovoRx, Inc. (RNXT)
RenovoRx, Inc. (RNXT)